Stay updated on L-DOS47 with Vinorelbine/Cisplatin in Lung Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the L-DOS47 with Vinorelbine/Cisplatin in Lung Adenocarcinoma Clinical Trial page.

Latest updates to the L-DOS47 with Vinorelbine/Cisplatin in Lung Adenocarcinoma Clinical Trial page
- CheckyesterdayChange DetectedFooter updated to display the new site revision (v3.3.3), replacing v3.3.2. The HHS Vulnerability Disclosure link was removed from the footer.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe page revision was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedRemoval of the government funding/operating status notice from the page; all study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check59 days agoChange DetectedNo significant content changes detected between the two screenshots; the page structure and key information such as the study title, conditions, locations, and eligibility criteria appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check80 days agoChange DetectedMajor addition of an operating-status notice and a v3.2.0 release; removal of the v3.1.0 tag indicating the new version.SummaryDifference3%

- Check87 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.1%

Stay in the know with updates to L-DOS47 with Vinorelbine/Cisplatin in Lung Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the L-DOS47 with Vinorelbine/Cisplatin in Lung Adenocarcinoma Clinical Trial page.